HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nutt, J.G. Articles by Burchiel, K.J. Search for Related Content PubMed PubMed Citation Articles by Nutt, J.G. Articles by Burchiel, K.J. Related Collections Parkinson's disease/Parkinsonism Surgery/Stimulation

Interactions between deep brain stimulation and levodopa in Parkinson’s disease

From the Departments of Neurology (Drs. Nutt and Hammerstad, S. Rufener, and J.H. Carter) and Neurological Surgery (Drs. Anderson and Burchiel), Oregon Health Sciences University, Portland; and Department of Neurology (Dr. Pahwa), University of Kansas, Kansas City.

Address correspondence and reprint requests to Dr. J.G. Nutt, Department of Neurology, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201; e-mail: nuttj{at}ohsu.edu

Objective:— To quantify the effects of deep brain stimulation (DBS) of globus pallidus interna (GPi) and subthalamic nucleus (STN) on motor fluctuations and dyskinesia in PD and to determine how the response to levodopa was modified by DBS.

Background:— Patients report that DBS reduces levodopa-induced motor fluctuations and dyskinesia throughout the day, but this has not been objectively measured. Further, the means by which DBS alters the response to levodopa to improve motor fluctuations is unknown.

Methods:— Twelve subjects, six with bilateral GPi electrodes and six with bilateral STN electrodes, were studied 12 to 33 months after surgery. To quantify motor fluctuations and dyskinesia, subjects were monitored hourly throughout 2 waking days with their usual oral medications, 1 day with DBS on and 1 day with DBS off, with subjects and nurse raters blinded to DBS status. To examine the effects of DBS on levodopa pharmacodynamics, the effects of a 2-hour levodopa infusion were examined, 1 day with DBS on and 1 day with DBS off, again under double-blind conditions. Time course of variations in parkinsonism was evaluated by tapping speed, arising and walking speed, tremor scores, and dyskinesia scores.

Results:— DBS raised the mean tapping speed and reduced the coefficient of variation during the waking day. This was achieved by increasing the lowest or trough tapping speed between doses of antiparkinson medications. Mean walking speed was modestly increased and mean tremor scores were reduced. DBS increased the drug-off tapping speed, but neither the peak response nor the duration of response to levodopa was affected by DBS. The study was not powered to detect differences between GPi and STN stimulation and the only difference that approached significance was that GPi reduced peak dyskinesia and STN tended to increase peak dyskinesia.

Conclusion:— DBS objectively reduces motor fluctuations. This is achieved by reduction of drug-off disability and not by alterations in levodopa pharmacodynamics. This finding suggests alleviation of interdose trough disability as an alternative strategy to prolonging the effects of each dose of levodopa as a means to reduce motor fluctuations.

This article has been cited by other articles:

				A. A. Kuhn, F. Kempf, C. Brucke, L. Gaynor Doyle, I. Martinez-Torres, A. Pogosyan, T. Trottenberg, A. Kupsch, G.-H. Schneider, M. I. Hariz, et al. High-Frequency Stimulation of the Subthalamic Nucleus Suppresses Oscillatory {beta} Activity in Patients with Parkinson's Disease in Parallel with Improvement in Motor Performance J. Neurosci., June 11, 2008; 28(24): 6165 - 6173. [Abstract] [Full Text] [PDF]

				C. Wider, H. Russmann, J.-G. Villemure, B. Robert, J. Bogousslavsky, P. R. Burkhard, and F. J. G. Vingerhoets Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Arch Neurol, July 1, 2006; 63(7): 951 - 955. [Abstract] [Full Text] [PDF]

				J. Baufreton, Z.-T. Zhu, M. Garret, B. Bioulac, S. W. Johnson, and A. I. Taupignon Dopamine receptors set the pattern of activity generated in subthalamic neurons FASEB J, November 1, 2005; 19(13): 1771 - 1777. [Abstract] [Full Text] [PDF]

				V. C. Anderson, K. J. Burchiel, P. Hogarth, J. Favre, and J. P. Hammerstad Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease Arch Neurol, April 1, 2005; 62(4): 554 - 560. [Abstract] [Full Text] [PDF]

				D. Nyholm, A. I.M. Nilsson Remahl, N. Dizdar, R. Constantinescu, B. Holmberg, R. Jansson, S. -M. Aquilonius, and H. Askmark Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease Neurology, January 25, 2005; 64(2): 216 - 223. [Abstract] [Full Text] [PDF]

				C. Maurer, T. Mergner, J. Xie, M. Faist, P. Pollak, and C. H. Lucking Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease Brain, May 1, 2003; 126(5): 1146 - 1163. [Abstract] [Full Text] [PDF]

				T. D. Sanger Pathophysiology of Pediatric Movement Disorders J Child Neurol, January 1, 2003; 18(1_suppl): S9 - S24. [Abstract] [PDF]

				E. Moro, R. J. A. Esselink, A. L. Benabid, and P. Pollak Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation Brain, November 1, 2002; 125(11): 2408 - 2417. [Abstract] [Full Text] [PDF]